Opinion: Everything you need to know about the dementia drug giving new hope

New drug, donanemab, has been shown to slow the progression of Alzheimer's disease. Professor John Hardy and Dr Cath Mummery (both UCL Queen Square Institute of Neurology) explain how it works and advances the field, but caution that it’s not a magic bullet, in the Daily Mail.